The majority of each pro-angiogenic factor in the tumor (∼81% of VEGF and ∼50% of FGF2) is bound to the cell surface, while only a small percentage of the anti-angiogenic factors (∼16% of PF4 and ∼12% of TSP1) exists on the cell surface. The gene discussed is FGF2; the disease is neoplasm.